To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
CRIL and CRB back SpiroGen
Cambridge Research BioVentures (CRB) and Cambridge Research and Innovation Ltd (CRIL) have led a £1m investment in Spirogen, which develops gene technology.
